Metabolic follow-up at one year and beyond of women with gestational diabetes treated with insulin and/or oral hypoglycaemic agents: study protocol for the identification of a core outcomes set using a Delphi survey

Show simple item record

dc.contributor.author Bogdanet, Delia
dc.contributor.author Egan, Aoife M.
dc.contributor.author Fhelelboom, Narjes
dc.contributor.author Biesty, Linda M.
dc.contributor.author Thangaratinam, Shakila
dc.contributor.author Dempsey, Eugene M.
dc.contributor.author Crowther, Caroline
dc.contributor.author Devane, Declan
dc.contributor.author Dunne, Fidelma P.
dc.date.accessioned 2019-05-16T15:26:53Z
dc.date.available 2019-05-16T15:26:53Z
dc.date.issued 2019-01-05
dc.identifier.citation Bogdanet, D., Egan, A., Fhelelboom, N., Biesty, L., Thangaratinam, S., Dempsey, E., Crowther, C., Devane, D. and Dunne, F., 2019. Metabolic follow-up at one year and beyond of women with gestational diabetes treated with insulin and/or oral hypoglycaemic agents: study protocol for the identification of a core outcomes set using a Delphi survey. Trials, 20(1).(7pp) DOI: 10.1186/s13063-018-3059-8 en
dc.identifier.volume 20 en
dc.identifier.startpage 1 en
dc.identifier.endpage 7 en
dc.identifier.issn 1745-6215
dc.identifier.uri http://hdl.handle.net/10468/7927
dc.identifier.doi 10.1186/s13063-018-3059-8 en
dc.description.abstract Gestational diabetes (GDM) is associated with an increased lifetime risk for the development of glucose abnormalities, metabolic syndrome, cardiovascular disease, depression and tumours. Despite this high risk of additional comorbidities, there is no standardised approach to the long-term follow-up of women with a previous diagnosis of GDM. Also, there is no standardisation of outcome selection and reporting in studies involving this population. This increases the risk of reporting bias and reduces the possibility of meaningful comparisons between studies. The aim of this study is to develop a protocol for a core outcome set (COS) for the metabolic follow-up at 1 year and beyond of women with previous GDM treated with insulin and/or oral hypoglycaemic agents. en
dc.format.mimetype application/pdf en
dc.language.iso en en
dc.publisher Springer Nature en
dc.relation.uri https://trialsjournal.biomedcentral.com/articles/10.1186/s13063-018-3059-8
dc.rights © The Author(s). 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. en
dc.rights.uri https://creativecommons.org/licenses/by/4.0/ en
dc.subject Core outcome set en
dc.subject Gestational diabetes en
dc.subject Insulin en
dc.subject Oral hypoglycaemic agents en
dc.title Metabolic follow-up at one year and beyond of women with gestational diabetes treated with insulin and/or oral hypoglycaemic agents: study protocol for the identification of a core outcomes set using a Delphi survey en
dc.type Article (peer-reviewed) en
dc.internal.authorcontactother Prof. Eugene Dempsey, Department of Paediatrics and Child Health, University College Cork, Cork, Ireland. +353-21-490-3000 Email: g.dempsey@ucc.ie en
dc.internal.availability Full text available en
dc.description.version Published Version en
dc.description.status Peer reviewed en
dc.identifier.journaltitle Trials en
dc.internal.IRISemailaddress g.dempsey@ucc.ie en
dc.identifier.articleid 9 en


Files in this item

This item appears in the following Collection(s)

Show simple item record

© The Author(s). 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. Except where otherwise noted, this item's license is described as © The Author(s). 2019. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
This website uses cookies. By using this website, you consent to the use of cookies in accordance with the UCC Privacy and Cookies Statement. For more information about cookies and how you can disable them, visit our Privacy and Cookies statement